Evidence map›Paper›PMID 36781597›Full record

ArticleGeroScience2023

Evaluating instruments for assessing healthspan: a multi-center cross-sectional study on health-related quality of life (HRQL) and frailty in the companion dog.

Frances L Chen, Tarini V Ullal, Jessica L Graves, Ellen R Ratcliff, Alexander Naka, Brennen McKenzie, Tennery A Carttar, Kaitlyn M Super, Jessica Austriaco, Sunny Y Weber and 2 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in GeroScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Frances L ChenCellular Longevity Inc., San Francisco, CA, USA. francesl.chen@umassmed.edu.ORCID 0000-0001-6441-9677
Tarini V UllalCellular Longevity Inc., San Francisco, CA, USA.ORCID 0000-0002-8728-3706
Jessica L GravesCellular Longevity Inc., San Francisco, CA, USA.ORCID 0000-0002-8227-1511
Ellen R RatcliffCellular Longevity Inc., San Francisco, CA, USA.
Alexander NakaCellular Longevity Inc., San Francisco, CA, USA.ORCID 0000-0003-0219-039X
Brennen McKenzieCellular Longevity Inc., San Francisco, CA, USA.ORCID 0000-0003-4097-8479
Tennery A CarttarCellular Longevity Inc., San Francisco, CA, USA.
Kaitlyn M SuperCellular Longevity Inc., San Francisco, CA, USA.
Jessica AustriacoCellular Longevity Inc., San Francisco, CA, USA.
Sunny Y WeberCellular Longevity Inc., San Francisco, CA, USA.
Julie VaughnCellular Longevity Inc., San Francisco, CA, USA.ORCID 0000-0002-9574-4437
Michael L LaCroix-FralishCellular Longevity Inc., San Francisco, CA, USA.ORCID 0000-0002-8850-5972
Human Longevity (United States) · USBroad Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing valid tools that assess key determinants of canine healthspan such as frailty and health-related quality of life (HRQL) is essential to characterizing and understanding aging in dogs. Additionally, because the companion dog is an excellent translational model for humans, such tools can be applied to evaluate gerotherapeutics and investigate mechanisms underlying longevity in both dogs and humans. In this multi-center, cross-sectional study, we investigated the use of a clinical questionnaire (Canine Frailty Index; CFI; Banzato et al., 2019) to assess frailty and an owner assessment tool (VetMetrica HRQL) to evaluate HRQL in 451 adult companion dogs. Results demonstrated validity of the tools by confirming expectations that frailty score increases and HRQL scores deteriorate with age. CFI scores were significantly higher (higher frailty) and HRQL scores significantly lower (worse HRQL) in old dogs (≥ 7 years of age) compared to young dogs (≥ 2 and < 6 years of age). Body size (small < 11.3 kg (25 lbs) or large > 22.7 kg (50 lbs)) was not associated with CFI or total HRQL score. However, older, larger dogs showed faster age-related decline in HRQL scores specific to owner-reported activity and comfort. Findings suggest that the clinician-assessed CFI and owner-reported VetMetrica HRQL are useful tools to evaluate two determinants of healthspan in dogs: the accumulation of frailty and the progressive decline in quality of life. Establishing tools that operationalize the assessment of canine healthspan is critical for the advancement of geroscience and the development of gerotherapeutics that benefit both human and veterinary medicine. Graphical summary of the design, results, and conclusions of the study.

Indexed as

FrailtyQuality of LifeAgingAnimalsCross-Sectional StudiesDogsHumansPetsCompanion dogComparative and translational agingFrailty indexHealth-related quality of lifeHealthspanMultimorbidity

Identifiers

PMID36781597
PMCPMC10651603
OpenAlexW4320556775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.